A meaningful prediction of functional decline in amyotrophic lateral sclerosis based on multi-event survival analysis
PLOS One · 18.11.2025 · 20 (11) · e0336476
DOI: 10.1371/journal.pone.0336476 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 18.11.2025. Verfasst von Christian Marius Lillelund und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Alberta Machine Intelligence Institute, Canadian Institute for Advanced Research.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of the motor neurons that causes progressive paralysis in patients. Current treatment options aim to prolong survival and improve quality of life. However, due to the heterogeneity of the disease, it is often difficult to determine the optimal time for potential therapies or medical interventions. In this study, we propose a novel method to predict the time until a patient with ALS experiences significant functional impairment (ALSFRS-R ≤ 2) for each of five common functions: speaking, swallowing, handwriting, walking, and breathing. We formulate this task as a multi-event survival problem and validate our approach in the PRO-ACT dataset ( N = 3 , 220 ) by training five covariate-based survival models to estimate the probability of each event over the 500 days following the baseline visit. We then predict five event-specific individual survival distributions (ISDs) for a patient, each providing an interpretable estimate of when that event is likely to occur. The results show that covariate-based models are superior to the Kaplan-Meier estimator at predicting time-to-event outcomes in the PRO-ACT dataset. Additionally, our method enables practitioners to make individual counterfactual predictions—where certain covariates can be changed—to estimate their effect on the predicted outcome. In this regard, we find that Riluzole has little or no impact on predicted functional decline. However, for patients with bulbar-onset ALS, our model predicts significantly shorter time-to-event estimates for loss of speech and swallowing function compared to patients with limb-onset ALS (log-rank p < 0.001, Bonferroni-adjusted α = 0.01 ). The proposed method can be applied to current clinical examination data to assess the risk of functional decline and thus allow more personalized treatment planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Computing Science, University of Alberta, Edmonton, Alberta, Canada.
- Department of Electrical and Computer Engineering, Aarhus University, Aarhus, Denmark.
- Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada.
- Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Alberta Machine Intelligence Institute, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Christian Marius Lillelund, Sanjay Kalra
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Alberta Machine Intelligence Institute
- Canadian Institute for Advanced Research
Zitieren
APA
Lillelund, C. M., Kalra, S., Greiner, R., & Pooled Resource Open-Access ALS Clinical Trials Consortium (PRO-ACT) (2025). A meaningful prediction of functional decline in amyotrophic lateral sclerosis based on multi-event survival analysis. PLOS One, 20(11), e0336476. https://doi.org/10.1371/journal.pone.0336476
Vancouver
Lillelund CM, Kalra S, Greiner R, Pooled Resource Open-Access ALS Clinical Trials Consortium (PRO-ACT). A meaningful prediction of functional decline in amyotrophic lateral sclerosis based on multi-event survival analysis. PLOS One. 2025;20(11):e0336476. doi:10.1371/journal.pone.0336476
BibTeX
@article{Lillelund2025,
author = {Lillelund, Christian Marius and Kalra, Sanjay and Greiner, Russell and Pooled Resource Open-Access ALS Clinical Trials Consortium (PRO-ACT), Pooled Resource Open-Access ALS Clinical Trials Consortium (PRO-ACT)},
title = {A meaningful prediction of functional decline in amyotrophic lateral sclerosis based on multi-event survival analysis},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {11},
pages = {e0336476},
doi = {10.1371/journal.pone.0336476}
}
EUVIMED